搜索临床试验以:厄洛替尼、培美曲塞
总计2401个结果
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
IO BiotechMerck Sharp & Dohme LLC完全的
-
Sichuan Cancer Hospital and Research InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的
-
Dutch Society of Physicians for Pulmonology and...完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
GlaxoSmithKline完全的
-
University of California, DavisNational Cancer Institute (NCI)完全的
-
Swiss Group for Clinical Cancer Research完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)撤销
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.完全的
-
Henan Provincial People's HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Eli Lilly and Company完全的非鳞状组织学的局部晚期或转移性 NSCLC 的组织学或细胞学诊断,且不适合治愈性治疗。匈牙利, 德国, 奥地利, 西班牙, 瑞典
-
Guangdong Association of Clinical Trials未知
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Finnish Lung Cancer GroupRoche Pharma AG完全的
-
The First Affiliated Hospital of Guangzhou Medical...尚未招聘
-
Henan Cancer HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.未知具有 T790M 阳性突变的 IIIb/IV NSCLC 奥希替尼治疗失败中国
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Sichuan UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Duke UniversityGenentech, Inc.完全的
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的